Drug intelligence / Profile preview

phyllodulcin

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Phyllodulcin is a natural dihydroisocoumarin compound extracted from the leaves of Hydrangea macrophylla var. thunbergii and Hydrangea serrata. It is primarily known as a high-intensity natural sweetener, being 400-800 times sweeter than sucrose. Pharmacologically, it acts as a non-selective phosphodiesterase (PDE) inhibitor. Research has demonstrated its potential in treating obesity by regulating adipogenesis and lipogenesis-related genes, and in diabetes by improving glucose homeostasis. It also exhibits anti-allergic properties through lymphocyte suppression and neuroprotective effects in Alzheimer's disease models by inhibiting amyloid-beta aggregation and reducing neuroinflammation. While it is a subject of significant pharmacological research, it is not currently developed as a commercial pharmaceutical drug by any specific company.

Other names
phyllodulcine
02

Targets

Amyloid-beta aggregate (N-terminal epitope)PDE (Phosphodiesterase family)

Beyond the preview

Go deeper on phyllodulcin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phyllodulcin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call